Comerica Bank’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $869K | Buy |
|
|||||
|
2025
Q1 | $776K | Sell |
|
|||||
|
2024
Q4 | $813K | Buy |
|
|||||
|
2024
Q3 | $757K | Buy |
|
|||||
|
2024
Q2 | $614K | Sell |
|
|||||
|
2024
Q1 | $573K | Sell |
|
|||||
|
2023
Q4 | $613K | Buy |
|
|||||
|
2023
Q3 | $474K | Buy |
|
|||||
|
2022
Q4 | $680K | Sell |
|
|||||
|
2022
Q3 | $1.06M | Sell |
|
|||||
|
2022
Q2 | $1.34M | Buy |
|
|||||
|
2022
Q1 | $1.47M | Buy |
|
|||||
|
2021
Q4 | $1.64M | Sell |
|
|||||
|
2021
Q3 | $2.06M | Sell |
|
|||||
|
2021
Q2 | $4.17M | Sell |
|
|||||
|
2021
Q1 | $6.17M | Sell |
|
|||||
|
2020
Q4 | $7.88M | Buy |
|
|||||
|
2020
Q3 | $4.47M | Buy |
|
|||||
|
2020
Q2 | $4.2M | Sell |
|
|||||
|
2020
Q1 | $3.56M | Buy |
|
|||||
|
2019
Q4 | $2.89M | Sell |
|
|||||
|
2019
Q3 | $3.66M | Buy |
|
|||||
|
2019
Q2 | $2.87M | Sell |
|
|||||
|
2019
Q1 | $3.5M | Sell |
|
|||||
|
2018
Q4 | $3.42M | Sell |
|
|||||
|
2018
Q3 | $5.54M | Sell |
|
|||||
|
2018
Q2 | $7.17M | Sell |
|
|||||
|
2018
Q1 | $5.59M | Buy |
|
|||||
|
2017
Q4 | $4.82M | Buy |
|
|||||
|
2017
Q3 | $3.79M | Buy |
|
|||||
|
2017
Q2 | $2.53M | Sell |
|
|||||
|
2017
Q1 | $2.38M | Buy |
|
|||||
|
2016
Q4 | $2.18M | Buy |
|
|||||
|
2016
Q3 | $1.92M | Buy |
|
|||||
|
2016
Q2 | $2.22M | Buy |
|
|||||
|
2016
Q1 | $2.29M | Buy |
|
|||||
|
2015
Q4 | $1.8M | Buy |
|
|||||
|
2015
Q3 | $1.56M | Sell |
|
|||||
|
2015
Q2 | $3.65M | Buy |
|
|||||
|
2015
Q1 | $1.36M | Sell |
|
|||||
|
2014
Q4 | $1.89M | Buy |
|
|||||
|
2014
Q3 | $876K | Sell |
|
|||||
|
2014
Q2 | $1.26M | Sell |
|
|||||
|
2014
Q1 | $1.37M | Sell |
|
|||||
|
2013
Q4 | $1.1M | Buy |
|